Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-2 receptor subunit alpha | ||
Ligand | BDBM50147983 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_89084 (CHEMBL878448) | ||
IC50 | 400000±n/a nM | ||
Citation | Raimundo, BC; Oslob, JD; Braisted, AC; Hyde, J; McDowell, RS; Randal, M; Waal, ND; Wilkinson, J; Yu, CH; Arkin, MR Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions. J Med Chem47:3111-30 (2004) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-2 receptor subunit alpha | |||
Name: | Interleukin-2 receptor subunit alpha | ||
Synonyms: | CD_antigen=CD25 | IL-2 receptor alpha subunit | IL-2-RA | IL2-RA | IL2RA_MOUSE | Il2r | Il2ra | Interleukin-2 receptor alpha chain | p55 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 30733.96 | ||
Organism: | Mus musculus | ||
Description: | ChEMBL_89085 | ||
Residue: | 268 | ||
Sequence: |
| ||
BDBM50147983 | |||
n/a | |||
Name | BDBM50147983 | ||
Synonyms: | 2-Cyclohexyl-N-(2-{4-[5-(2,3-dichloro-phenyl)-4-methyl-4H-pyrazol-3-yl]-piperidin-1-yl}-2-oxo-ethyl)-2-guanidino-acetamide | CHEMBL105251 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H35Cl2N7O2 | ||
Mol. Mass. | 548.508 | ||
SMILES | Cc1c([nH]nc1-c1cccc(Cl)c1Cl)C1CCN(CC1)C(=O)CNC(=O)[C@H](N=C(N)N)C1CCCCC1 |wD:26.29,(-4.64,-2.92,;-4.33,-1.4,;-2.93,-.75,;-3.12,.77,;-4.64,1.07,;-5.38,-.28,;-6.91,-.45,;-7.83,.79,;-9.37,.6,;-9.98,-.82,;-9.05,-2.05,;-9.68,-3.46,;-7.53,-1.87,;-6.62,-3.11,;-1.59,-1.5,;-1.58,-3.06,;-.25,-3.8,;1.08,-3.02,;1.07,-1.48,;-.27,-.72,;2.43,-3.78,;2.43,-5.32,;3.74,-2.99,;5.09,-3.76,;6.42,-2.97,;6.4,-1.43,;7.75,-3.73,;9.08,-2.95,;10.43,-3.69,;10.44,-5.23,;11.76,-2.92,;7.78,-5.27,;6.45,-6.04,;6.45,-7.58,;7.79,-8.34,;9.12,-7.56,;9.11,-6.02,)| | ||
Structure |